Technical Articles

Digestive system
KRAS G12D抑制剂联合免疫治疗在胰腺癌中的应用前景
The application prospects of KRAS G12D inhibitors combined with immunotherapy in pancreatic cancer
发布时间 2026-03-03
Pancreatic cancer is one of the most malignant tumors in the digestive system, ranking among the leading causes of cancer-related deaths due to its difficulty in early diagnosis, rapid progression, and limited treatment options.
View details
  • Cancer
  • KRAS G12D & CRBN Binding Kit (GTP load)
  • Pancreatic cancer
  • Digestive system
Total 1
  • 1
Go to
UA
Link：
Products
Application
Cell FactorTarget Proteins
Custom Services
Custom Protein Expression ServicesCustom SPR Services
About Us
PromotionTechnical ArticlesProduct ApplicationFAQsCitationsAbout Us
We Media：
Facebook Linkedin YouTube X Thraeds Pinterest
©2021-2026 all rights reserved UA Biotechnology Co.,Ltd.
Privacy Policy
网站备案号 浙ICP备2022019033号-2 浙公网安备33010202004867号
 Business license (three certificates in one)
Tel：+86-25-56221161
E-mail：order@ua-bio.com
All products sold on this website shall not be used for clinical diagnosis or treatment of humans or animals, and shall only be used for non-medical purposes such as industrial or scientific research.